- Home
- ALLO vs FLWS Comparison
ALLO vs FLWS Comparison
Compare ALLO & FLWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLO
- FLWS
- Stock Information
- Founded
- ALLO 2017
- FLWS 1976
- Country
- ALLO United States
- FLWS United States
- Employees
- ALLO N/A
- FLWS N/A
- Industry
- ALLO Biotechnology: Biological Products (No Diagnostic Substances)
- FLWS Other Specialty Stores
- Sector
- ALLO Health Care
- FLWS Consumer Discretionary
- Exchange
- ALLO Nasdaq
- FLWS Nasdaq
- Market Cap
- ALLO 252.9M
- FLWS 268.5M
- IPO Year
- ALLO 2018
- FLWS 1999
- Fundamental
- Price
- ALLO $1.21
- FLWS $3.71
- Analyst Decision
- ALLO Buy
- FLWS Hold
- Analyst Count
- ALLO 12
- FLWS 1
- Target Price
- ALLO $8.80
- FLWS $7.50
- AVG Volume (30 Days)
- ALLO 2.9M
- FLWS 2.7M
- Earning Date
- ALLO 11-13-2025
- FLWS 10-30-2025
- Dividend Yield
- ALLO N/A
- FLWS N/A
- EPS Growth
- ALLO N/A
- FLWS N/A
- EPS
- ALLO N/A
- FLWS N/A
- Revenue
- ALLO N/A
- FLWS $1,685,658,000.00
- Revenue This Year
- ALLO N/A
- FLWS N/A
- Revenue Next Year
- ALLO $100.00
- FLWS $0.92
- P/E Ratio
- ALLO N/A
- FLWS N/A
- Revenue Growth
- ALLO N/A
- FLWS N/A
- 52 Week Low
- ALLO $0.86
- FLWS $3.70
- 52 Week High
- ALLO $3.78
- FLWS $9.24
- Technical
- Relative Strength Index (RSI)
- ALLO 49.04
- FLWS 37.23
- Support Level
- ALLO $1.21
- FLWS $3.70
- Resistance Level
- ALLO $1.26
- FLWS $4.95
- Average True Range (ATR)
- ALLO 0.08
- FLWS 0.53
- MACD
- ALLO -0.01
- FLWS -0.02
- Stochastic Oscillator
- ALLO 14.18
- FLWS 3.57
About ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.
About FLWS 1-800-FLOWERS.COM Inc.
1-800-Flowers.com Inc is a provider of gifts designed to help customers express, connect, and celebrate. The company's e-commerce business platform features all brands, including 1-800-Flowers.com, 1-800-Baskets.com, Cheryl's Cookies, Harry and David, PersonalizationMall.com, Shari's Berries, FruitBouquets.com, Moose Munch, The Popcorn Factory, Wolferman's Bakery, Stock Yards, and Simply Chocolate. The company's business segments are; Consumer Floral and Gifts, BloomNet, and Gourmet Foods & Gift Baskets. The maximum revenue for the company is generated from its Gourmet Foods & Gift Baskets segment.